{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:41:26Z","timestamp":1789792886402,"version":"4.0.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31872787"],"award-info":[{"award-number":["31872787"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070462"],"award-info":[{"award-number":["82070462"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81921001"],"award-info":[{"award-number":["81921001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91939105"],"award-info":[{"award-number":["91939105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170476"],"award-info":[{"award-number":["82170476"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["M21008"],"award-info":[{"award-number":["M21008"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyperhomocysteinemia (HHcy) is a risk factor for chronic kidney diseases (CKDs) that affects about 85% CKD patients. HHcy stimulates B cells to secrete pathological antibodies, although it is unknown whether this pathway mediates kidney injury. In HHcy-treated 2-kidney, 1-clip (2K1C) hypertensive murine model, HHcy-activated B cells secreted anti-beta 2 glycoprotein I (\u03b2<jats:sub>2<\/jats:sub>GPI) antibodies that deposited in glomerular endothelial cells (GECs), exacerbating glomerulosclerosis and reducing renal function. Mechanistically, HHcy 2K1C mice increased phosphatidylethanolamine (PE) (18:0\/20:4, 18:0\/22:6, 16:0\/20:4) in kidney tissue, as determined by lipidomics. GECs oxidative lipidomics validated the increase of oxidized phospholipids upon Hcy-activated B cells culture medium (Hcy-B CM) treatment, including PE (18:0\/20:4\u2009+\u20093[O], PE (18:0a\/22:4\u2009+\u20091[O], PE (18:0\/22:4\u2009+\u20092[O] and PE (18:0\/22:4\u2009+\u20093[O]). PE synthases ethanolamine kinase 2 (etnk2) and ethanolamine-phosphate cytidylyltransferase 2 (pcyt2) were increased in the kidney GECs of HHcy 2K1C mice and facilitated polyunsaturated PE synthesis to act as lipid peroxidation substrates. In HHcy 2K1C mice and Hcy-B CM-treated GECs, the oxidative environment induced by iron accumulation and the insufficient clearance of lipid peroxides caused by transferrin receptor (TFR) elevation and down-regulation of SLC7A11\/glutathione peroxidase 4 (GPX4) contributed to GECs ferroptosis of the kidneys. In vivo, pharmacological depletion of B cells or inhibition of ferroptosis mitigated the HHcy-aggravated hypertensive renal injury. Consequently, our findings uncovered a novel mechanism by which B cell-derived pathogenic anti-\u03b2<jats:sub>2<\/jats:sub>GPI IgG generated by HHcy exacerbated hypertensive kidney damage by inducing GECs ferroptosis. Targeting B cells or ferroptosis may be viable therapeutic strategies for ameliorating lipid peroxidative renal injury in HHcy patients with hypertensive nephropathy.<\/jats:p>","DOI":"10.1038\/s41392-023-01313-x","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T01:02:54Z","timestamp":1678669374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["B cell-derived anti-beta 2 glycoprotein I antibody mediates hyperhomocysteinemia-aggravated hypertensive glomerular lesions by triggering ferroptosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Xing","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changtao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6720-6810","authenticated-orcid":false,"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"1313_CR1","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/S0140-6736(07)60854-X","volume":"369","author":"X Wang","year":"2007","unstructured":"Wang, X. et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 369, 1876\u20131882 (2007).","journal-title":"Lancet"},{"key":"1313_CR2","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1001\/jama.2015.2274","volume":"313","author":"Y Huo","year":"2015","unstructured":"Huo, Y. et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. J. Am. Med. Assoc. 313, 1325\u20131335 (2015).","journal-title":"J. Am. Med. Assoc."},{"key":"1313_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nm0496-386","volume":"2","author":"KS McCully","year":"1996","unstructured":"McCully, K. S. Homocysteine and vascular disease. Nat. Med. 2, 386\u2013389 (1996).","journal-title":"Nat. Med."},{"key":"1313_CR4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.clinbiochem.2012.05.031","volume":"45","author":"CC Wu","year":"2012","unstructured":"Wu, C. C. et al. Role of homocysteine in end-stage renal disease. Clin. Biochem. 45, 1286\u20131294 (2012).","journal-title":"Clin. Biochem."},{"key":"1313_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1053\/j.ajkd.2009.01.266","volume":"54","author":"J Heinz","year":"2009","unstructured":"Heinz, J., Kropf, S., Luley, C. & Dierkes, J. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis. Am. J. Kidney Dis. 54, 478\u2013489 (2009).","journal-title":"Am. J. Kidney Dis."},{"key":"1313_CR6","doi-asserted-by":"publisher","first-page":"e2389","DOI":"10.1097\/MD.0000000000002389","volume":"94","author":"L Yun","year":"2015","unstructured":"Yun, L. et al. Homocysteine and the C677T gene polymorphism of its key metabolic enzyme MTHFR are risk factors of early renal damage in hypertension in a chinese han population. Medicine 94, e2389 (2015).","journal-title":"Medicine"},{"key":"1313_CR7","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1159\/000486013","volume":"42","author":"ZM Kuang","year":"2017","unstructured":"Kuang, Z. M., Wang, Y., Feng, S. J., Jiang, L. & Cheng, W. L. Association between plasma homocysteine and microalbuminuria in untreated patients with essential hypertension: a case-control study. Kidney Blood Press. Res 42, 1303\u20131311 (2017).","journal-title":"Kidney Blood Press. Res"},{"key":"1313_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-733","volume":"11","author":"F Marti","year":"2011","unstructured":"Marti, F. et al. Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. BMC Public Health 11, 733 (2011).","journal-title":"BMC Public Health"},{"key":"1313_CR9","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1093\/ndt\/gft206","volume":"28","author":"B Ponte","year":"2013","unstructured":"Ponte, B. et al. Determinants and burden of chronic kidney disease in the population-based CoLaus study: a cross-sectional analysis. Nephrol. Dial. Transpl. 28, 2329\u20132339 (2013).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1313_CR10","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S2213-8587(14)70102-0","volume":"2","author":"Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration.","year":"2014","unstructured":"Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2, 634\u2013647 (2014).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1313_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang, L. et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379, 815\u2013822 (2012).","journal-title":"Lancet"},{"key":"1313_CR12","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nri3523","volume":"13","author":"C Kurts","year":"2013","unstructured":"Kurts, C., Panzer, U., Anders, H. J. & Rees, A. J. The immune system and kidney disease: basic concepts and clinical implications. Nat. Rev. Immunol. 13, 738\u2013753 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"1313_CR13","first-page":"685","volume":"34","author":"SC Sommers","year":"1958","unstructured":"Sommers, S. C., Relman, A. S. & Smithwick, R. H. Histologic studies of kidney biopsy specimens from patients with hypertension. Am. J. Pathol. 34, 685\u2013715 (1958).","journal-title":"Am. J. Pathol."},{"key":"1313_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41577-019-0160-5","volume":"19","author":"GR Drummond","year":"2019","unstructured":"Drummond, G. R., Vinh, A., Guzik, T. J. & Sobey, C. G. Immune mechanisms of hypertension. Nat. Rev. Immunol. 19, 517\u2013532 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1313_CR15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/HYPERTENSIONAHA.115.05779","volume":"66","author":"CT Chan","year":"2015","unstructured":"Chan, C. T. et al. Obligatory role for B cells in the development of angiotensin II-dependent. Hypertens. Hypertens. 66, 1023\u20131033 (2015).","journal-title":"Hypertens. Hypertens."},{"key":"1313_CR16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S0008-6363(01)00376-5","volume":"52","author":"Q Zhang","year":"2001","unstructured":"Zhang, Q., Zeng, X., Guo, J. & Wang, X. Effects of homocysteine on murine splenic B lymphocyte proliferation and its signal transduction mechanism. Cardiovasc. Res. 52, 328\u2013336 (2001).","journal-title":"Cardiovasc. Res."},{"key":"1313_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4049\/jimmunol.1600613","volume":"198","author":"J Deng","year":"2017","unstructured":"Deng, J. et al. Homocysteine activates B cells via regulating PKM2-dependent metabolic reprogramming. J. Immunol. 198, 170\u2013183 (2017).","journal-title":"J. Immunol."},{"key":"1313_CR18","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/cvr\/cvz288","volume":"116","author":"F Shao","year":"2020","unstructured":"Shao, F. et al. B cell-derived anti-beta 2 glycoprotein I antibody contributes to hyperhomocysteinaemia-aggravated abdominal aortic aneurysm. Cardiovasc. Res. 116, 1897\u20131909 (2020).","journal-title":"Cardiovasc. Res."},{"key":"1313_CR19","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1056\/NEJMra1705454","volume":"378","author":"D Garcia","year":"2018","unstructured":"Garcia, D. & Erkan, D. Diagnosis and management of the antiphospholipid syndrome. New Engl. J. Med. 378, 2010\u20132021 (2018).","journal-title":"New Engl. J. Med."},{"key":"1313_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.kint.2016.06.026","volume":"91","author":"F Bienaime","year":"2017","unstructured":"Bienaime, F., Legendre, C., Terzi, F. & Canaud, G. Antiphospholipid syndrome and kidney disease. Kidney Int. 91, 34\u201344 (2017).","journal-title":"Kidney Int."},{"key":"1313_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11926-009-0074-5","volume":"12","author":"D Kumar","year":"2010","unstructured":"Kumar, D. & Roubey, R. A. Use of rituximab in the antiphospholipid syndrome. Curr. Rheumatol. Rep. 12, 40\u201344 (2010).","journal-title":"Curr. Rheumatol. Rep."},{"key":"1313_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/BOR.0000000000000051","volume":"26","author":"S Sciascia","year":"2014","unstructured":"Sciascia, S., Khamashta, M. A. & D\u2019Cruz, D. P. Targeted therapy in antiphospholipid syndrome. Curr. Opin. Rheumatol. 26, 269\u2013275 (2014).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1313_CR23","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"1313_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang, D., Chen, X., Kang, R. & Kroemer, G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 31, 107\u2013125 (2021).","journal-title":"Cell Res."},{"key":"1313_CR25","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell, B. R. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell 185, 2401\u20132421 (2022).","journal-title":"Cell"},{"key":"1313_CR26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/hep.29117","volume":"66","author":"H Wang","year":"2017","unstructured":"Wang, H. et al. Characterization of ferroptosis in murine models of hemochromatosis. Hepatology 66, 449\u2013465 (2017).","journal-title":"Hepatology"},{"key":"1313_CR27","doi-asserted-by":"publisher","first-page":"360438","DOI":"10.1155\/2014\/360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala, A., Munoz, M. F. & Arguelles, S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell. Longev. 2014, 360438 (2014).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"1313_CR28","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.3390\/ijms20194968","volume":"20","author":"N Kajarabille","year":"2019","unstructured":"Kajarabille, N. & Latunde-Dada, G. O. Programmed cell-death by ferroptosis: antioxidants as mitigators. Int. J. Mol. Sci. 20, 4968 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1313_CR29","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc. Cell Death Differ. 27, 662\u2013675 (2020).","journal-title":"Cell Death Differ."},{"key":"1313_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/ars.2017.7115","volume":"29","author":"M Maiorino","year":"2018","unstructured":"Maiorino, M., Conrad, M. & Ursini, F. GPx4, lipid peroxidation, and cell death: discoveries, rediscoveries, and open issues. Antioxid. Redox Signal. 29, 61\u201374 (2018).","journal-title":"Antioxid. Redox Signal."},{"key":"1313_CR31","doi-asserted-by":"publisher","first-page":"19395","DOI":"10.1074\/jbc.RA119.010949","volume":"294","author":"L Su","year":"2019","unstructured":"Su, L. et al. Pannexin 1 mediates ferroptosis that contributes to renal ischemia\/reperfusion injury. J. Biol. Chem. 294, 19395\u201319404 (2019).","journal-title":"J. Biol. Chem."},{"key":"1313_CR32","doi-asserted-by":"publisher","first-page":"626390","DOI":"10.3389\/fendo.2021.626390","volume":"12","author":"X Feng","year":"2021","unstructured":"Feng, X. et al. Ferroptosis enhanced diabetic renal tubular injury via HIF-1alpha\/HO-1 pathway in db\/db Mice. Front. Endocrinol. 12, 626390 (2021).","journal-title":"Front. Endocrinol."},{"key":"1313_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrneph.2017.155","volume":"14","author":"S Agrawal","year":"2018","unstructured":"Agrawal, S., Zaritsky, J. J., Fornoni, A. & Smoyer, W. E. Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat. Rev. Nephrol. 14, 57\u201370 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"1313_CR34","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.3390\/ijms21072632","volume":"21","author":"L Opazo-Rios","year":"2020","unstructured":"Opazo-Rios, L. et al. Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities. Int. J. Mol. Sci. 21, 2632 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1313_CR35","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00109-018-1645-6","volume":"96","author":"S Lu","year":"2018","unstructured":"Lu, S. et al. PKM2-dependent metabolic reprogramming in CD4(+) T cells is crucial for hyperhomocysteinemia-accelerated atherosclerosis. J. Mol. Med. 96, 585\u2013600 (2018).","journal-title":"J. Mol. Med."},{"key":"1313_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ebiom.2018.04.022","volume":"31","author":"SY Zhang","year":"2018","unstructured":"Zhang, S. Y. et al. Adipocyte-derived lysophosphatidylcholine activates adipocyte and adipose tissue macrophage Nod-like receptor protein 3 inflammasomes mediating homocysteine-induced insulin resistance. EBioMedicine 31, 202\u2013216 (2018).","journal-title":"EBioMedicine"},{"key":"1313_CR37","doi-asserted-by":"publisher","first-page":"101742","DOI":"10.1016\/j.redox.2020.101742","volume":"37","author":"Y Yan","year":"2020","unstructured":"Yan, Y. et al. Homocysteine promotes hepatic steatosis by activating the adipocyte lipolysis in a HIF1alpha-ERO1alpha-dependent oxidative stress manner. Redox Biol. 37, 101742 (2020).","journal-title":"Redox Biol."},{"key":"1313_CR38","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1001\/jamainternmed.2016.4687","volume":"176","author":"X Xu","year":"2016","unstructured":"Xu, X. et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the renal substudy of the china stroke primary prevention trial. JAMA Intern. Med. 176, 1443\u20131450 (2016).","journal-title":"JAMA Intern. Med."},{"key":"1313_CR39","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1161\/01.HYP.0000028489.29543.58","volume":"40","author":"CH Yen","year":"2002","unstructured":"Yen, C. H. & Lau, Y. T. Vascular responses in male and female hypertensive rats with hyperhomocysteinemia. Hypertension 40, 322\u2013328 (2002).","journal-title":"Hypertension"},{"key":"1313_CR40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/0929867324666170509145240","volume":"25","author":"O Karmin","year":"2018","unstructured":"Karmin, O. & Siow, Y. L. Metabolic imbalance of homocysteine and hydrogen sulfide in kidney disease. Curr. Med. Chem. 25, 367\u2013377 (2018).","journal-title":"Curr. Med. Chem."},{"key":"1313_CR41","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/iub.354","volume":"62","author":"F Gibellini","year":"2010","unstructured":"Gibellini, F. & Smith, T. K. The Kennedy pathway-De novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life 62, 414\u2013428 (2010).","journal-title":"IUBMB Life"},{"key":"1313_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2016.10.086","volume":"482","author":"MM Gaschler","year":"2017","unstructured":"Gaschler, M. M. & Stockwell, B. R. Lipid peroxidation in cell death. Biochem. Biophys. Res. Commun. 482, 419\u2013425 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1313_CR43","first-page":"385","volume":"41","author":"DS Bilan","year":"2015","unstructured":"Bilan, D. S., Shokhina, A. G., Lukyanov, S. A. & Belousov, V. V. [Main Cellular Redox Couples]. Bioorg. Khim. 41, 385\u2013402 (2015).","journal-title":"Bioorg. Khim."},{"key":"1313_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang, W. S. & Stockwell, B. R. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 26, 165\u2013176 (2016).","journal-title":"Trends Cell Biol."},{"key":"1313_CR45","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tibs.2015.11.012","volume":"41","author":"AR Bogdan","year":"2016","unstructured":"Bogdan, A. R., Miyazawa, M., Hashimoto, K. & Tsuji, Y. Regulators of iron homeostasis: new players in metabolism, cell death, and disease. Trends Biochem. Sci. 41, 274\u2013286 (2016).","journal-title":"Trends Biochem. Sci."},{"key":"1313_CR46","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage, T. et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385, 1975\u20131982 (2015).","journal-title":"Lancet"},{"key":"1313_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/srep16268","volume":"5","author":"D Xie","year":"2015","unstructured":"Xie, D. et al. Hyperhomocysteinemia predicts renal function decline: a prospective study in hypertensive adults. Sci. Rep. 5, 16268 (2015).","journal-title":"Sci. Rep."},{"key":"1313_CR48","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/S0140-6736(05)66583-X","volume":"365","author":"SJ Chadban","year":"2005","unstructured":"Chadban, S. J. & Atkins, R. C. Glomerulonephritis. Lancet 365, 1797\u20131806 (2005).","journal-title":"Lancet"},{"key":"1313_CR49","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/S0140-6736(16)00272-5","volume":"387","author":"J Floege","year":"2016","unstructured":"Floege, J. & Amann, K. Primary glomerulonephritides. Lancet 387, 2036\u20132048 (2016).","journal-title":"Lancet"},{"key":"1313_CR50","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","volume":"74","author":"R Cervera","year":"2015","unstructured":"Cervera, R. et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann. Rheum. Dis. 74, 1011\u20131018 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"1313_CR51","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1182\/blood-2011-09-378851","volume":"120","author":"T Colasanti","year":"2012","unstructured":"Colasanti, T. et al. Autoantibodies specific to a peptide of beta2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes. Blood 120, 3360\u20133370 (2012).","journal-title":"Blood"},{"key":"1313_CR52","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.5551\/jat.24372","volume":"21","author":"X Zhang","year":"2014","unstructured":"Zhang, X. et al. Involvement of TLR4 in oxidized LDL\/beta2GPI\/anti-beta2GPI-induced transformation of macrophages to foam cells. J. Atheroscler. Thromb. 21, 1140\u20131151 (2014).","journal-title":"J. Atheroscler. Thromb."},{"key":"1313_CR53","first-page":"556","volume":"6","author":"A Blum","year":"2004","unstructured":"Blum, A. & Simsolo, C. The antiphospholipid syndrome and endothelial function. Isr. Med. Assoc. J. 6, 556\u2013558 (2004).","journal-title":"Isr. Med. Assoc. J."},{"key":"1313_CR54","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","volume":"7","author":"PL Meroni","year":"2011","unstructured":"Meroni, P. L., Borghi, M. O., Raschi, E. & Tedesco, F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat. Rev. Rheumatol. 7, 330\u2013339 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1313_CR55","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.jacc.2017.02.058","volume":"69","author":"MT Corban","year":"2017","unstructured":"Corban, M. T. et al. Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics. J. Am. Coll. Cardiol. 69, 2317\u20132330 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1313_CR56","first-page":"254","volume":"39","author":"W Zhao","year":"2021","unstructured":"Zhao, W., Gao, F., Lv, L. & Chen, X. The interaction of hypertension and homocysteine increases the risk of mortality among middle-aged and older population in the United States. J. Hypertens. 39, 254\u2013263 (2021).","journal-title":"J. Hypertens."},{"key":"1313_CR57","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil, G. S. Inflammation, metaflammation and immunometabolic disorders. Nature 542, 177\u2013185 (2017).","journal-title":"Nature"},{"key":"1313_CR58","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1074\/jbc.M114.551051","volume":"289","author":"FJ Dufort","year":"2014","unstructured":"Dufort, F. J. et al. Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation. J. Biol. Chem. 289, 7011\u20137024 (2014).","journal-title":"J. Biol. Chem."},{"key":"1313_CR59","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.bbrc.2007.04.016","volume":"357","author":"L Chang","year":"2007","unstructured":"Chang, L. et al. Liver-X-receptor activator prevents homocysteine-induced production of IgG antibodies from murine B lymphocytes via the ROS-NF-kappaB pathway. Biochem. Biophys. Res. Commun. 357, 772\u2013778 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1313_CR60","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.autrev.2011.04.011","volume":"10","author":"C Alessandri","year":"2011","unstructured":"Alessandri, C., Conti, F., Pendolino, M., Mancini, R. & Valesini, G. New autoantigens in the antiphospholipid syndrome. Autoimmun. Rev. 10, 609\u2013616 (2011).","journal-title":"Autoimmun. Rev."},{"key":"1313_CR61","doi-asserted-by":"crossref","unstructured":"Gai, Z. et al. Lipid accumulation and chronic kidney disease. Nutrients 11, 722 (2019).","DOI":"10.3390\/nu11040722"},{"key":"1313_CR62","doi-asserted-by":"crossref","unstructured":"Han, L. et al. The binding of autotaxin to integrins mediates hyperhomocysteinemia-potentiated platelet activation and thrombosis. Blood Adv. 6, 46\u201361 (2022).","DOI":"10.1182\/bloodadvances.2021004572"},{"key":"1313_CR63","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1161\/ATVBAHA.115.306964","volume":"36","author":"X Li","year":"2016","unstructured":"Li, X. et al. Mitochondrial reactive oxygen species mediate lysophosphatidylcholine-induced endothelial cell activation. Arterioscler. Thromb. Vasc. Biol. 36, 1090\u20131100 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1313_CR64","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1089\/ars.2017.7069","volume":"28","author":"Y Shao","year":"2018","unstructured":"Shao, Y. et al. Lysophospholipids and their receptors serve as conditional DAMPs and DAMP Receptors in Tissue Oxidative and Inflammatory Injury. Antioxid. Redox Signal. 28, 973\u2013986 (2018).","journal-title":"Antioxid. Redox Signal."},{"key":"1313_CR65","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1194\/jlr.M013292","volume":"52","author":"DL Golej","year":"2011","unstructured":"Golej, D. L. et al. Long-chain acyl-CoA synthetase 4 modulates prostaglandin E(2) release from human arterial smooth muscle cells. J. Lipid Res. 52, 782\u2013793 (2011).","journal-title":"J. Lipid Res."},{"key":"1313_CR66","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S. et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13, 91\u201398 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"1313_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03135-z","volume":"11","author":"C Ding","year":"2020","unstructured":"Ding, C. et al. miR-182-5p and miR-378a-3p regulate ferroptosis in I\/R-induced renal injury. Cell Death Dis. 11, 929 (2020).","journal-title":"Cell Death Dis."},{"key":"1313_CR68","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.celrep.2019.07.107","volume":"28","author":"WH Yang","year":"2019","unstructured":"Yang, W. H. et al. The hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma. Cell Rep. 28, 2501\u20132508 e2504 (2019).","journal-title":"Cell Rep."},{"key":"1313_CR69","doi-asserted-by":"publisher","first-page":"16836","DOI":"10.1073\/pnas.1415518111","volume":"111","author":"A Linkermann","year":"2014","unstructured":"Linkermann, A. et al. Synchronized renal tubular cell death involves ferroptosis. Proc. Natl Acad. Sci. USA 111, 16836\u201316841 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1313_CR70","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1002\/art.10542","volume":"46","author":"J Delgado Alves","year":"2002","unstructured":"Delgado Alves, J. et al. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Arthritis Rheum. 46, 2686\u20132694 (2002).","journal-title":"Arthritis Rheum."},{"key":"1313_CR71","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1055\/s-0037-1615012","volume":"79","author":"PR Ames","year":"1998","unstructured":"Ames, P. R. et al. Oxidative stress in primary antiphospholipid syndrome. Thromb. Haemost. 79, 447\u2013449 (1998).","journal-title":"Thromb. Haemost."},{"key":"1313_CR72","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2020.11.024","volume":"81","author":"B Yan","year":"2021","unstructured":"Yan, B. et al. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol. Cell. 81, 355\u2013369.e310 (2021).","journal-title":"Mol. Cell."},{"key":"1313_CR73","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","volume":"16","author":"Y Zou","year":"2020","unstructured":"Zou, Y. et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat. Chem. Biol. 16, 302\u2013309 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"1313_CR74","doi-asserted-by":"publisher","first-page":"17835","DOI":"10.1021\/jacs.8b09913","volume":"140","author":"TS Anthonymuthu","year":"2018","unstructured":"Anthonymuthu, T. S. et al. Empowerment of 15-lipoxygenase catalytic competence in selective oxidation of membrane ETE-PE to ferroptotic death signals, HpETE-PE. J. Am. Chem. Soc. 140, 17835\u201317839 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"1313_CR75","doi-asserted-by":"publisher","first-page":"101328","DOI":"10.1016\/j.redox.2019.101328","volume":"28","author":"G Miotto","year":"2020","unstructured":"Miotto, G. et al. Insight into the mechanism of ferroptosis inhibition by ferrostatin-1. Redox Biol. 28, 101328 (2020).","journal-title":"Redox Biol."},{"key":"1313_CR76","doi-asserted-by":"publisher","first-page":"101744","DOI":"10.1016\/j.redox.2020.101744","volume":"38","author":"TS Anthonymuthu","year":"2021","unstructured":"Anthonymuthu, T. S. et al. Resolving the paradox of ferroptotic cell death: Ferrostatin-1 binds to 15LOX\/PEBP1 complex, suppresses generation of peroxidized ETE-PE, and protects against ferroptosis. Redox Biol. 38, 101744 (2021).","journal-title":"Redox Biol."},{"key":"1313_CR77","doi-asserted-by":"publisher","first-page":"e148671","DOI":"10.1172\/JCI148671","volume":"131","author":"N Koleini","year":"2021","unstructured":"Koleini, N., Shapiro, J. S., Geier, J. & Ardehali, H. Ironing out mechanisms of iron homeostasis and disorders of iron deficiency. J. Clin. Invest. 131, e148671 (2021).","journal-title":"J. Clin. Invest."},{"key":"1313_CR78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang, X., Ardehali, H., Min, J. & Wang, F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat. Rev. Cardiol. 20, 7\u201323 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"1313_CR79","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s42255-021-00425-4","volume":"3","author":"SM Lam","year":"2021","unstructured":"Lam, S. M. et al. A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19. Nat. Metab. 3, 909\u2013922 (2021).","journal-title":"Nat. Metab."},{"key":"1313_CR80","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","volume":"133","author":"TM Seibt","year":"2019","unstructured":"Seibt, T. M., Proneth, B. & Conrad, M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic. Biol. Med. 133, 144\u2013152 (2019).","journal-title":"Free Radic. Biol. Med."},{"key":"1313_CR81","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/cdd.2015.93","volume":"23","author":"M Hayano","year":"2016","unstructured":"Hayano, M., Yang, W. S., Corn, C. K., Pagano, N. C. & Stockwell, B. R. Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation. Cell Death Differ. 23, 270\u2013278 (2016).","journal-title":"Cell Death Differ."},{"key":"1313_CR82","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.yjmcc.2008.09.708","volume":"46","author":"DM Harris","year":"2009","unstructured":"Harris, D. M. et al. Inhibition of angiotensin II Gq signaling augments beta-adrenergic receptor mediated effects in a renal artery stenosis model of high blood pressure. J. Mol. Cell. Cardiol. 46, 100\u2013107 (2009).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1313_CR83","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/ki.1987.189","volume":"32","author":"AM el Nahas","year":"1987","unstructured":"el Nahas, A. M., Zoob, S. N., Evans, D. J. & Rees, A. J. Chronic renal failure after nephrotoxic nephritis in rats: contributions to progression. Kidney Int. 32, 173\u2013180 (1987).","journal-title":"Kidney Int."},{"key":"1313_CR84","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1084\/jem.200116116","volume":"195","author":"VM Holers","year":"2002","unstructured":"Holers, V. M. et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J. Exp. Med. 195, 211\u2013220 (2002).","journal-title":"J. Exp. Med."},{"key":"1313_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09277-9","volume":"10","author":"Y Zou","year":"2019","unstructured":"Zou, Y. et al. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nat. Commun. 10, 1617 (2019).","journal-title":"Nat. Commun."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01313-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01313-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01313-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T01:03:05Z","timestamp":1678669385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01313-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1313"],"URL":"https:\/\/doi.org\/10.1038\/s41392-023-01313-x","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"31 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}